Complement Inhibition in Xenotransplantation–Where Should the Complement Cascade be Inhibited?
Clinical gene‐edited pig organ xenotransplantation has recently become a reality, but some problems remain. The transgenic expression of human complement‐regulatory proteins in the pig organs is now an accepted means of reducing the impact of complement activation, and immunosuppressive therapy based on CD40/CD154 co‐stimulation pathway blockade has proven a largely effective regimen. However, the potential role of complement inhibitors remains uncertain. The complement cascade is complex and consists of several major pathways (e.g., classical, lectin, alternative, terminal) but with several amplification loops and bypasses. It can be inhibited at several different sites, for example, C1, C3, C5, Factor B, and Factor D. We discuss the effect of the various inhibitors currently available and consider their advantages and disadvantages in relation to xenotransplantation. We tentatively suggest that a C3/C3b complement inhibitor may prove optimal, and that complement inhibition may need to be extended for a prolonged period of time.
No keywords indexed for this article. Browse by subject →
Tatsuo Kawai, Winfred W. Williams, Nahel Elias et al.
Anne Geller, Jun Yan
Daniel Ricklin, George Hajishengallis, Kun Yang et al.
- Published
- Sep 01, 2025
- Vol/Issue
- 32(5)
- License
- View
You May Also Like
Vered Padler‐Karavani, Ajit Varki · 2011
144 citations
Nicole Kirchhof, Satoshi Shibata · 2004
130 citations
Guerard Byrne, Saadullah Ahmad‐Villiers · 2018
112 citations
Robert Rieben, Edith von Allmen · 1995
65 citations
Raphael P.H. Meier, Alban Longchamp · 2021
29 citations